LoginRegister

    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  

    New Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action indicated (VAI) classification for its Ahmedabad SEZ facility.


    The United States Food and Drug Administration (USFDA) had conducted an inspection of the company's formulations manufacturing facility located at SEZ, Ahmedabad from March 25 to April 3, 2019, Cadila Healthcare said in a BSE filing.


    Read Also: Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    The plant has received an establishment inspection report (EIR). The EIR report stated that the classification of the facility is VAI, it added.


    As per the USFDA, VAI means that though "objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action".


    Read Also: Cadila Healthcare posts Q4 net profit of Rs 460 crore


    BSECadila Ahmedabad SEZ facilityCadila HealthcareDrug firm Cadila HealthcareEIREstablishment Inspection ReportShares of Cadila HealthcareUnited States Food and Drug AdministrationUS healthUSFDAVAIVoluntary Action Indicated
    Source : Cadila Healthcare

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X